| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 13.338 | 104.369 | 71.131 | 62.737 |
| Total Income - EUR | - | - | - | - | - | - | 13.338 | 104.546 | 72.455 | 63.391 |
| Total Expenses - EUR | - | - | - | - | - | - | 10.557 | 23.379 | 33.487 | 52.177 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.781 | 81.167 | 38.969 | 11.214 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 2.665 | 80.247 | 38.259 | 9.542 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Bobiţ Therapie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 839 | 1.952 | 23.088 | 58.106 |
| Current Assets | - | - | - | - | - | - | 3.696 | 82.697 | 19.460 | 18.318 |
| Inventories | - | - | - | - | - | - | 0 | 1.176 | 1.172 | 1.166 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 1.327 | 8.041 |
| Cash | - | - | - | - | - | - | 3.696 | 81.522 | 16.961 | 9.111 |
| Shareholders Funds | - | - | - | - | - | - | 2.705 | 82.961 | 40.614 | 49.928 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.830 | 1.740 | 2.039 | 26.627 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bobiţ Therapie S.r.l.